These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23838217)

  • 1. Influence of state laws mandating reporting of healthcare-associated infections: the case of central line-associated bloodstream infections.
    Pakyz AL; Edmond MB
    Infect Control Hosp Epidemiol; 2013 Aug; 34(8):780-4. PubMed ID: 23838217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative.
    Marsteller JA; Hsu YJ; Weeks K
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S209-15. PubMed ID: 25239712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating systematic misclassification of central line-associated bloodstream infection (CLABSI) to secondary bloodstream infection during health care-associated infection reporting.
    Thompson ND; Yeh LL; Magill SS; Ostroff SM; Fridkin SK
    Am J Med Qual; 2013; 28(1):56-9. PubMed ID: 22679125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of State Reporting Laws on Central Line-Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units.
    Liu H; Herzig CTA; Dick AW; Furuya EY; Larson E; Reagan J; Pogorzelska-Maziarz M; Stone PW
    Health Serv Res; 2017 Jun; 52(3):1079-1098. PubMed ID: 27451968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009.
    Oh JY; Cunningham MC; Beldavs ZG; Tujo J; Moore SW; Thomas AR; Cieslak PR
    Infect Control Hosp Epidemiol; 2012 May; 33(5):439-45. PubMed ID: 22476268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of hospital administrative data in reporting central line-associated bloodstream infections in newborns.
    Patrick SW; Davis MM; Sedman AB; Meddings JA; Hieber S; Lee GM; Stillwell TL; Chenoweth CE; Espinosa C; Schumacher RE
    Pediatrics; 2013 Mar; 131 Suppl 1():S75-80. PubMed ID: 23457153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Mandatory Public Reporting of Central Line-Associated Bloodstream Infections on Blood Culture and Antibiotic Utilization in Pediatric and Neonatal Intensive Care Units.
    Flett KB; Ozonoff A; Graham DA; Sandora TJ; Priebe GP
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):878-85. PubMed ID: 25913602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of state legal mandates for data submission of central line-associated bloodstream infections in neonatal intensive care units with process and outcome measures.
    Zachariah P; Reagan J; Furuya EY; Dick A; Liu H; Herzig CT; Pogorzelska-Maziarz M; Stone PW; Saiman L
    Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1133-9. PubMed ID: 25111921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of multiple concurrent central venous catheters on central line-associated bloodstream infections.
    Concannon C; van Wijngaarden E; Stevens V; Dumyati G
    Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1140-6. PubMed ID: 25111922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the surveillance and reporting of central line-associated bloodstream infection data to a state health department.
    Backman LA; Melchreit R; Rodriguez R
    Am J Infect Control; 2010 Dec; 38(10):832-8. PubMed ID: 21093699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denominator doesn't matter: standardizing healthcare-associated infection rates by bed days or device days.
    Horstman MJ; Li YF; Almenoff PL; Freyberg RW; Trautner BW
    Infect Control Hosp Epidemiol; 2015 Jun; 36(6):710-6. PubMed ID: 25782986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multicenter Longitudinal Study of Hospital-Onset Bacteremia: Time for a New Quality Outcome Measure?
    Rock C; Thom KA; Harris AD; Li S; Morgan D; Milstone AM; Caffo B; Joshi M; Leekha S
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):143-8. PubMed ID: 26493213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unit-Level Changes in Central Line-Associated Bloodstream Infection Before and After Implementation of the Affordable Care Act and Mandatory Reporting Legislation.
    Woodward BC; Umberger RA
    Dimens Crit Care Nurs; 2018; 37(1):35-43. PubMed ID: 29194173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discord among performance measures for central line-associated bloodstream infection.
    Tehrani DM; Russell D; Brown J; Boynton-Delahanty K; Quan K; Gibbs L; Braddock G; Zaroda T; Koopman M; Thompson D; Nichols A; Cui E; Liu C; Cohen S; Rubin Z; Pegues D; Torriani F; Datta R; Huang SS
    Infect Control Hosp Epidemiol; 2013 Feb; 34(2):176-83. PubMed ID: 23295564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013.
    Epstein L; See I; Edwards JR; Magill SS; Thompson ND
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):2-7. PubMed ID: 26456954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central-line associated bloodstream infections in a tertiary care children's University hospital: a prospective study.
    Venturini E; Montagnani C; Benni A; Becciani S; Biermann KP; De Masi S; Chiappini E; de Martino M; Galli L;
    BMC Infect Dis; 2016 Dec; 16(1):725. PubMed ID: 27903240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laws pertaining to healthcare-associated infections: a review of 3 legal requirements.
    Reagan J; Hacker C
    Infect Control Hosp Epidemiol; 2012 Jan; 33(1):75-80. PubMed ID: 22173526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State health department validations of central line-associated bloodstream infection events reported via the National Healthcare Safety Network.
    Bagchi S; Watkins J; Pollock DA; Edwards JR; Allen-Bridson K
    Am J Infect Control; 2018 Nov; 46(11):1290-1295. PubMed ID: 29903420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal barrier injury laboratory-confirmed bloodstream infection: results from a field test of a new National Healthcare Safety Network definition.
    See I; Iwamoto M; Allen-Bridson K; Horan T; Magill SS; Thompson ND
    Infect Control Hosp Epidemiol; 2013 Aug; 34(8):769-76. PubMed ID: 23838215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of 2015 NHSN Catheter-associated Urinary Tract Infection (CAUTI) Definition Change on Central Line-associated Bloodstream Infection (CLABSI) Rates and CLABSI Prevention Efforts at an Academic Medical Center.
    Advani SD; Lee RA; Long M; Schmitz M; Camins BC
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):878-880. PubMed ID: 29665877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.